Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
The ever-increasing threat from "superbugs" -- strains of pathogenic bacteria that are impervious to the antibiotics that subdued their predecessor generations -- has forced the medical community to look for bactericidal weapons outside the realm of traditional drugs. One promising candidate is the antimicrobial peptide (AMP), one of Mother Nature's lesser-known defenses against infections, that kills a pathogen by creating, then expanding, nanometer-sized pores in the cell membrane until it bursts. However, before this phenomenon can be exploited as a medical therapy, researchers need a better understanding of how AMPs and membranes interact at the molecular level.
Using a novel imaging technique, a research team led by the United Kingdom's National Physical Laboratory (NPL) is helping acquire much-needed insight into the fundamental physical and chemical processes that occur when AMPs bind with membranes and form pores in them. Team leader Paulina D. Rakowska will discuss the latest aspects of this work during the AVS 60th International Symposium & Exhibition, which was held recently in Long Beach, Calif.
Observing the formation of pores in live cell membranes by naturally occurring AMPs is difficult because researchers have no control over the steps in the complex process. In many cases, the membranes of the target cell leak, swell and rupture before individual pores can expand enough to be examined. Rakowska and her colleagues have overcome this obstacle by combining nanoscale imaging via two different systems, computer simulation, a made-from-scratch (de novo) AMP, and lipid bilayers fixed to a solid surface (known as a supported lipid bilayer or SLB).
With the ability to specifically test where and how the de novo peptide binds to the SLB, the pore formation process is opened up to direct observation. Atomic force microscopy (AFM) provides topographical (structural) imaging of the peptide-treated membrane while chemical analysis is done with high-resolution nanoscale secondary ion mass spectroscopy (NanoSIMS).
"Data from the AFM images suggests that membranes change as a result of peptide action and pore formation," Rakowska says. "NanoSIMS imaging performed on the same samples reveal the precise location of peptide molecules within the membranes."
Rakowska says that these observations provide the first-ever physical and visual evidence of antimicrobial pore expansion from nano-to-micrometer scale to the point of complete membrane disintegration. "We can now postulate the mechanism by which this occurs," she explains. "We believe that the first AMPs binding with the membrane actively 'recruit' others to do the same, resulting in the formation of numerous small pores. As these pores expand, they eventually lead to membrane disintegration and cell death."
The research team includes scientists from the NPL, the London Centre for Nanotechnology, University College London, the University of Oxford, the University of Edinburgh, Freie University Berlin and IBM. The team's latest publication, "Nanoscale imaging reveals laterally expanding antimicrobial pores in lipid bilayers," recently appeared in the Proceedings of the National Academy of Sciences USA.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our MRSA / Drug Resistance category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
American Institute of Physics. "Novel imaging technique, a new weapon in the fight against superbugs." Medical News Today. MediLexicon, Intl., 4 Nov. 2013. Web.
10 Dec. 2013. <http://www.medicalnewstoday.com/releases/268232>
American Institute of Physics. (2013, November 4). "Novel imaging technique, a new weapon in the fight against superbugs." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/268232.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.